neurocare group AG Receives EUR 19.3 Million Investment From Impact Expansion and TVM Capital Healthcare
MUNICH, BRUSSELS, RIYADH, DE / ACCESS Newswire / February 5, 2025 / neurocare group AG ('neurocare' or the 'Company'), a leading mental health platform, is pleased to announce a EUR19.3 million investment from Impact Expansion, an impact-driven European private equity firm based in Luxembourg with offices in Brussels and Paris and from existing neurocare shareholder TVM Capital Healthcare. This investment demonstrates strong confidence in neurocare's strategy and supports the company's continued global growth.
This funding will enable neurocare to further develop its technologies and services as well as expand its international footprint of mental health clinics.
neurocare´s best practice mental health platform empowers clinicians to provide personalized treatment for a range of psychological or neurological conditions. The platform integrates innovative mental health care methods and tools such as sleep hygiene, rTMS, QEEG and neurofeedback with existing approaches such as talk therapy and pharmaceuticals. These assets are all embedded within a cloud-based solution to drive productivity and improve outcomes. Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing individualized therapy plans, scientifically proven to deliver superior clinical outcomes for Depression, ADHD, mental performance and other indications.
According to the World Health Organization, globally, 12.9% of people are affected by mental disorders, with associated costs projected to rise from $2.5 trillion in 2010 to $6 trillion by 2030. During the COVID pandemic, diagnoses of mental illnesses doubled, yet access to adequate treatment remains limited in many countries. This gap highlights a significant growth opportunity for neurocare providing innovative, non-invasive treatments with superior clinical outcomes by empowering clinicians to deliver best practice.
Erick Rinner, Partner, Impact Expansion ( www.impact-expansion.com), stated: 'We firmly believe that neurocare is uniquely positioned to lead the way in addressing the growing global mental health crisis. Their care infrastructure and innovative best-practice mental health platform represents a much-needed and timely advancement in the industry. We look forward to supporting Thomas and his management team to become a leading force within the mental health care sector.'
Tristan de Boysson, Managing Partner, TVM Capital Healthcare ( www.tvmcapitalhealthcare.com), added: 'Our continued investment in neurocare is a clear reflection of our confidence in their vision and progress. We are excited to further support their efforts in delivering effective mental health solutions globally, and particularly in markets such as Saudi Arabia with tremendous growth prospects for specialty care and government support for improving access to mental healthcare.'
Thomas Mechtersheimer, Founder and CEO of neurocare group ( www.neurocaregroup.com), said: 'This investment by another internationally renowned impact investor plus a follow-on investment from TVM Capital Healthcare is a strong endorsement of our progress and reinforces the confidence in our executive team and strategy. We will now drive the company's growth and empower many more clinicians to support many more patients with our best practice platform.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
5 high-yield stock picks to add to your dividend portfolio
It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth. Does the prospect of economic uncertainty have you rethinking your portfolio? Perhaps you'd like to collect a little more cash while the economic headwinds are blowing? It's not an unreasonable concern. Plenty of other investors are already thinking more defensively. To this end, here's a closer look at five high-yielding dividend stocks to consider adding to your portfolio sooner rather than later, until it's clear the worst is behind us. 1. Verizon Communications Dividend yield: 6.2% Verizon Communications is, of course, one of the country's biggest wireless service providers, boasting well over 100 million paying customers who collectively handed over nearly $135 billion worth of revenue last year alone. Of that, $18 billion was turned into net income, $11.25 billion of which was dished out to shareholders in the form of dividends. That's in line with the company's long-term norms. There is an arguable downside here. That's growth ... or lack thereof. The well-saturated U.S. wireless market doesn't offer much in the way of upside potential above and beyond simple population growth. Verizon is finding some inroads within the institutional/private 5G communications space, but that's a highly competitive market. There's just not a ton of expansion to be added here either. What Verizon may lack in growth potential, however, it more than makes up for in consistency and sheer payout. Nobody's interested in giving up their mobile phones, which supports a sizable forward-looking yield of 6.2% that's based on a dividend that has now been raised for 18 consecutive years. Not bad. 2. Realty Income Dividend yield: 5.6% Realty Income isn't a stock in the traditional sense. Rather, it's a real estate investment trust, or REIT. That just means it owns a portfolio of rent-bearing real estate. REITs trade just like ordinary stocks do, and pay dividends the same way that dividend stocks do, too. And Realty Income brings something else to the table that's pretty unique in addition to its sizable forward-looking yield of 5.6%. That's a monthly dividend payment, as opposed to the quarterly cadence you'll get with most other dividend stocks. Realty Income's specialty is retailing real estate. In light of the so-called "retail apocalypse" that seems to never end, this focus seems like a liability. But take a step back and look at the bigger picture. While numbers from Coresight Research point out that 7,325 U.S. stores were shuttered last year, 5,970 new stores were opened (or reopened). Realty Income further narrows this gap by serving the strongest survivors in the business. Its top tenants include 7-Eleven, Dollar General, Dollar Tree, and FedEx, just to name a few. Underscoring the quality caliber of its renters is the fact that its occupancy rate currently stands at an industry-beating 98.5%, and only fell to 97.9% in COVID-crimped 2020. This resilience is one of the reasons the REIT has been able to raise its payout annually for the past 30 consecutive years. 3. SPDR Portfolio S&P 500 High Dividend ETF Dividend yield: 4.6% Speaking of dividend stocks that aren't actually stocks, add the SPDR Portfolio S&P 500 High Dividend ETF (NYSEMKT: SPYD) to your watch list, if not to your portfolio. An ETF (or exchange-traded fund) is a basket of stocks with a common characteristic. In this instance, these tickers are all part of the S&P 500 High Dividend Index, which tracks the 80 highest-yielding names within the S&P 500. These include Philip Morris, toymaker Hasbro, AT&T, and Ford Motor Company, for reference. None of these names has a great deal of growth firepower. All of them, however, are healthy dividend payers. Most of them also have a solid track record of dividend growth, even if it's not required for inclusion in the underlying index. Sure, you can probably find higher dividend yields than the one SPYD offers. The aforementioned Realty Income and Verizon both boast bigger ones, for instance. The SPDR Portfolio S&P 500 High Dividend ETF is still an incredibly simple way of achieving a well-diversified mix of dividend stocks though, with a little more potential for capital appreciation than Verizon or Realty Income offer. 4. Pfizer Dividend yield: 6.9% It's no secret that drugmaker Pfizer (NYSE: PFE) has underperformed since the wind-down of COVID-19, which upended sales of its Paxlovid approved to treat the disease. The company's top line has slipped from 2022's $100 billion to only $64 billion last year, for perspective, and analysts aren't looking for any sales growth this year or next either. That's the chief reason Pfizer shares continue to flounder. If you can look just a little further down the road, though, some new blockbuster drugs are in the works -- drugs like vepdegestrant, for the treatment of ER+/HER2- metastatic breast cancer. While it will be competing with plenty of other therapies in this same space, it's noteworthy that the FDA fast-tracked this drug, which is being co-developed with Arvinas. And that's just one. Pfizer got a total of four promising oncology drugs with its 2023 acquisition of Seagen, and now has over 100 clinical trials underway, 30 of which are in phase 3 (late-stage) testing. Indeed, the company believes it's got eight oncology candidates in its developmental pipeline that could become blockbusters by 2030. Little of this long-term upside is being reflected in the stock's present price, however, even though it arguably should be. More to the point for interested income investors, this pharmaceutical stock's weakness has pushed its forward-looking dividend yield up to nearly 7% at a point where the pharma giant is on the verge of significant prolonged revenue and profit growth. 5. Global X Nasdaq 100 Covered Call ETF Dividend yield: 14% Finally, consider adding a stake in the Global X Nasdaq 100 Covered Call ETF (NASDAQ: QYLD) to your dividend portfolio. It's not a stock. It's an exchange-traded fund. And an unusual one at that. While it holds the same tickers that make up the tech-heavy Nasdaq-100 index, serving as an index fund isn't its primary purpose. Rather, this ETF's purpose is to generate reliable income that's regularly distributed to shareholders by selling covered calls against the ETF's stock holdings. It's an income-generating process called "buy-write," in fact -- you're buying a stock, and then "writing" (or selling) call options on those shares, essentially using them as collateral. And the process works. Although the income generated by writing covered calls over and over again can be erratic (don't count on that trailing 14% yield going forward), the resulting reliable yields are typically big even if they're not precisely predictable. There's also a big downside, though. That is, this fund is almost certainly guaranteed to underperform the Nasdaq-100 itself, even after factoring in all of its sizable dividend payments. That's just the nature of selling covered calls -- the strategy doesn't let you fully participate when the market's rallying the most. Writing options is just a means of monetizing stock holdings when they're mostly moving sideways, or losing ground. Still, with a double-digit yield, even only capturing a portion of the Nasdaq-100's long-term upside isn't a bad bet. It's just arguably not the only dividend-paying investment you'd want to own at any given time, mostly due to its inconsistent payments. James Brumley has positions in AT&T. The Motley Fool has positions in and recommends FedEx, Pfizer, and Realty Income. The Motley Fool recommends Hasbro, Philip Morris International, and Verizon Communications. The Motley Fool has a disclosure policy. The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY. Should you invest $1,000 in Pfizer right now? Offer from the Motley Fool: Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025
Business of Fashion
3 hours ago
- Business of Fashion
This Week: What's Ailing Louis Vuitton?
What's Happening: The luxury downturn is deepening, with sector bellwether LVMH expected to report a double-digit decline in its fashion and leather goods division when the group reports quarterly sales and first-half profits July 24. Is Bigger Still Better? In previous slowdowns like the 2008 financial crisis or Covid-19 pandemic, LVMH's staggering scale and exposure across competing categories helped it hold up better and bounce back more quickly than rivals. This time, jewellery-focused Richemont, standalone giant Hermès and smaller groups like Prada, Moncler, Zegna and Brunello Cucinelli have proved more resilient while LVMH's woes deepened. Unjustified price hikes — or 'greedflation' — in the group's key handbag category is largely to blame. The group is also navigating a generational shift in its top ranks. LVMH's marketing budgets and clout with landlords remain unparalleled. But in today's fast-changing luxury market, more focused companies appear to have the advantage when it comes to nimble decision-making and execution. The coming quarters will show whether the conglomerate's current down cycle represents a blip or a paradigm shift. Vuitton Under the Microscope: LVMH is facing challenges across key units — from layoffs at Moët Hennessey to falling sales at Dior to lacklustre performance at duty-free retailer DFS. But with a designer transition underway at Dior and new management in place at Moët, those works-in-progress are increasingly seen by investors as yesterday's story. Reviving momentum at Louis Vuitton, the group's biggest and most profitable brand, is now top of mind. 'The biggest luxury brand on the planet and more than half of the group's EBIT seems to be at a crossroads,' HSBC analyst Erwan Rambourg wrote last month in a note to clients. 'The aspirational skew of the brand is unhelpful currently. A schizophrenic pull between low-end (chocolate, beauty) and high-end (exclusive leather ranges), fashion content (Murakami) and more subtle travel-related luxury items begs the question: What does LV really stand for? Who is it targeting? What is its USP?' The creation of a new deputy CEO position (bringing over former Loro Piana chief Damien Bertrand in March to support chief executive Pietro Beccari) was a 'red flag' signalling challenges at the brand, Rambourg said. Balancing a variety of messages including hyper-visibility and sophistication, top-end and aspirational price points, core products and brand extensions has long been a part of the mega-brand formula. But another quarter of losing market share to the likes of Hermès and Prada — as analysts are currently forecasting — will lead investors to wonder: What's the plan? The Week Ahead wants to hear from you! Send tips, suggestions, complaints and compliments to Disclosure: LVMH is part of a group of investors who, together, hold a minority interest in The Business of Fashion. All investors have signed shareholders' documentation guaranteeing BoF's complete editorial independence.
Business Insider
5 hours ago
- Business Insider
Here are the 10 most expensive cities for the ultra-rich in 2025 — and the quiet power shift shaping the next luxury capitals
For the third year running, Singapore ranked as the world's most expensive city for high-net-worth individuals, according to the latest Global Wealth and Lifestyle Report from Julius Baer Group, a Swiss wealth management group. London moved into second place, nudging Hong Kong into third — but behind these familiar frontrunners, a quiet transformation could soon redraw the global map for the super wealthy The 2025 edition of the report, published on Monday, tracked the cost of what it called "living well" — meaning the ability to afford and regularly spend on 20 luxury goods and services that high-net-worth individuals typically enjoy. These include private school fees, luxury property, watches, fancy dinners, and business class flights. Pricing data was collected across 25 cities between November 2024 and March 2025, and each city was ranked based on the weighted-average total cost of all 20 items, converted into US dollars. To complement the price index, Julius Baer also conducted a separate Lifestyle Survey, polling 360 high-net-worth individuals across 15 countries in February and March 2025 to understand how the wealthy are spending and investing. While the methodology is robust, it does not account for geopolitical shifts that followed, including the Trump administration's April tariff announcements, and its relatively small sample size may limit broad conclusions. Still, the findings point to a clear shift in momentum: while the podium remains stable, several key cities — especially in Asia and the Middle East — are climbing fast, suggesting a broader power shift in global luxury hubs. The top 10 most expensive cities for the wealthy in 2025 Singapore. London. Hong Kong. Monaco. Zurich. Shanghai. Dubai. New York. Paris. Milan. The quiet rise of new luxury capitals Several emerging cities climbed the rankings at an unexpected pace, especially in Asia and the Middle East. Dubai jumped five spots to 7th place, edging closer to European strongholds like Monaco and Zurich. Bangkok and Tokyo both rose six positions, landing at 11th and 17th, respectively, driven by rising costs of fashion, watches, and property. Bangkok's "growing upper-middle class has had a direct impact on the expansion of the local luxury market," Rishabh Saksena, cohead of Julius Baer's global asset class specialists, told Business Insider. "Increased wealth has mechanically driven demand for luxury goods and services, allowing the development of luxury malls, fine dining, and experiences such as spas," he said. "Additionally, the city benefits from Asia's long-standing appeal as a global tourism destination." Tokyo's rise reflects a similar trend. " Tokyo, and Japan more broadly, has long been a culturally rich and influential region, with a strong luxury market, especially in areas such as fashion, fine dining, and experiences," Saksena added. "The recent global shift among HNWIs toward valuing experiences over goods has further enhanced Tokyo's attractivity and appeal." Meanwhile, Shanghai, which topped the index in 2022, fell from 4th to 6th place — a sign that its dominance may be fading So Paulo and Mexico City also dropped notably in the rankings. "Dubai is nipping at the heels of the bastion cities in the region for wealth and lifestyle — London, Monaco, and Zurich — in a trend that is likely to continue as the Emirate ups the ante on offering an attractive residence proposition for HNWIs," the report said. Behind the movements is a growing desire among the ultrawealthy for stability, wellness, and future-focused cities. The report also notes that Dubai's appeal lies in tax advantages, luxury infrastructure, and a booming property market, while Bangkok and Tokyo benefit from regional economic momentum and cultural cachet. What's driving the change? The global average cost of "living well" actually declined 2% in US dollar terms between 2024 and 2025 — a rare drop in a sector typically shielded from macroeconomic headwinds. Yet, beneath that decline are sharp regional contrasts: Business class air fares jumped 18.2% globally, driven by a shortage of jets and booming demand for premium pleasure travel. Luxury goods like handbags and jewellery fell in price, reflecting shifting consumer priorities. Private school fees soared in cities like London, where new tax rules drove up costs by over 25%. More broadly, high-net-worth individuals increasingly prioritize experiences over possessions and longevity over status. These include spending more on wellness, curated travel, and health services, especially in Asia-Pacific and the Middle East. "The main shift we've seen recently is the growing move toward aspirational consumption among HNWIs, who increasingly value experiences over physical goods," Mark Matthews, Head of Research Asia at Julius Baer, told BI. "This trend varies from one location to another. Markets with a long cultural history of luxury goods (e.g., Switzerland with watches or Germany with cars) tend to show a slower transition toward 'experience-based' spending," he added. Data from the Lifestyle Survey backs this up. While luxury spending growth has cooled in Europe — where only 36% of high-net-worth individuals reported spending more on hotels — HNWIs in Asia-Pacific, the Middle East, and Latin America continue to ramp up their spending on high-end fashion, jewellery, and watches. In APAC, 65% reported increasing spending on both hotels and watches, and 63% on women's fashion. In the Middle East, 52% spent more on hotels and 50% on fine jewellery. Across the board, travel and hospitality remain top spending priorities, with fine dining and five-star hotels leading the way. A Eurasian future? The report also hints at a broader geopolitical rebalancing in how — and where — the world's wealthy choose to live. "There is already talk of many wealthy Americans decamping to Europe for the next four years — and possibly forever," Julius Baer's report said, citing affluent individuals looking for political stability and strong institutions. Cities like London, despite Brexit and political change, remain magnets for global wealth thanks to world-class education, healthcare, and cultural capital.
